MESNEX Drug Patent Profile
✉ Email this page to a colleague
When do Mesnex patents expire, and what generic alternatives are available?
Mesnex is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in MESNEX is mesna. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mesna profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mesnex
A generic version of MESNEX was approved as mesna by FRESENIUS KABI USA on April 26th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MESNEX?
- What are the global sales for MESNEX?
- What is Average Wholesale Price for MESNEX?
Summary for MESNEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 120 |
Clinical Trials: | 90 |
Patent Applications: | 1,250 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MESNEX |
What excipients (inactive ingredients) are in MESNEX? | MESNEX excipients list |
DailyMed Link: | MESNEX at DailyMed |
![MESNEX drug patent expirations Drug patent expirations by year for MESNEX](/p/graph/s/t/MESNEX-patent-expirations.png)
![Drug Prices for MESNEX](/p/graph/drug-price/MESNEX.png)
Recent Clinical Trials for MESNEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Markus Mapara | Phase 1/Phase 2 |
ITB-Med LLC | Phase 1/Phase 2 |
Ossium Health, Inc. | Phase 1/Phase 2 |
Pharmacology for MESNEX
Drug Class | Cytoprotective Agent |
US Patents and Regulatory Information for MESNEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MESNEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MESNEX
See the table below for patents covering MESNEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Yugoslavia | 122691 | ⤷ Sign Up | |
Austria | 358162 | ⤷ Sign Up | |
Brazil | 9304151 | ⤷ Sign Up | |
Bulgaria | 60901 | ⤷ Sign Up | |
Australia | 667129 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |